Lantheus Medical Imaging parent company Lantheus Holdings has appointed Dr. Jean-Claude Provost as interim chief medical officer (CMO). His appointment is effective immediately.
With more than 30 years of experience in international development of therapeutic drugs and diagnostic agents, Provost joins Lantheus from his pharmaceutical and biotechnology consultant firm, Theranostics Consulting.
